Company Analysis

CNS Pharmaceuticals, Inc. (CNSP)

Nasdaq: CNSP · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2018
Grade4.1
◀ Past 3.1● Present 2.4▶ Future 6.2
6 est.

Filings

300 filings since 2017 beside 90 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Aug 21, 2026.

Filings a yearinsider forms included
3146314368874433
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Oct 2, 2026.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Sep 18, 2024.SEC letters: 36 in the last 36 months, the newest May 22, 2026.
Insider forms 90

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 2, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Sep 30, 2026
Aug 25, 2026 DEFA14A Extra proxy material
Aug 21, 2026 DEF 14A Proxy statement Sep 30, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Jul 2, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 26, 2026 EFFECT Registration effective
May 26, 2026 424B3 Shelf offering
May 22, 2026 CORRESP Reply to the SEC
May 22, 2026 UPLOAD SEC comment letter
May 19, 2026 D Private placement notice
May 19, 2026 S-3 Shelf registration
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 4, 2026 8-K items 1.01, 3.02, 5.02, 9.01 Major agreement signed; Shares sold without registration; Officer or director change · Current report
Apr 30, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 17, 2026 SCHEDULE 13G Large holder notice
Mar 31, 2026 10-K Annual report Dec 31, 2025
Mar 11, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 2, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Feb 26, 2026
Feb 27, 2026 S-8 Employee stock plan registration
Feb 17, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Feb 10, 2026
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Dec 17, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Dec 16, 2025
Nov 21, 2025 8-K items 5.02, 5.03, 5.07, 9.01 Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote · Current report Nov 17, 2025
Nov 14, 2025 10-Q Quarterly report Sep 30, 2025
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 12, 2025 DEFA14A Extra proxy material
Nov 4, 2025 SCHEDULE 13G Large holder notice
Oct 28, 2025 ARS Annual report to shareholders Dec 31, 2024
Oct 24, 2025 DEF 14A Proxy statement Nov 17, 2025
Oct 10, 2025 PRE 14A Preliminary proxy statement Nov 17, 2025
Sep 19, 2025 424B5 Shelf offering
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Aug 14, 2025 SCHEDULE 13G Large holder notice
Jul 22, 2025 8-K items 3.03, 5.03, 8.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report Jul 17, 2025
Jul 15, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 15, 2025 10-Q Quarterly report Mar 31, 2025
May 15, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report May 13, 2025
May 14, 2025 424B4 Offering prospectus
40 of 300 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CNSP · research, not advice